The association of APE1 -656T > G and 1349 T > G polymorphisms and cancer risk: A meta-analysis based on 37 case-control studies

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Zhou, Bin ^a   Shan, Hailin ^a   Su, Ying ^a   Xia, Kai ^a   Shao, Xiaxia ^a   Mao, Weidong ^a   Shao, Qing ^a,b  

^a SOUTHEAST UNIVERSITY   (China)

^b JIANGYIN PEOPLE S HOSPITAL   (China)

Author keywords

Cancer risk; Cape1; Meta analysis; Single nucleotide polymorphism

Indexed keywords

APE1 PROTEIN; APURINIC OR APYRIMIDINIC ENDONUCLEASE 1; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; UNCLASSIFIED DRUG; APEX1 PROTEIN, HUMAN;

ARTICLE; ASIAN; BILIARY TRACT CANCER; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; ESOPHAGUS CANCER; ETHNIC GROUP; EUROPEAN; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HEAD AND NECK CANCER; HETEROZYGOTE; HOMOZYGOTE; HUMAN; KIDNEY CARCINOMA; LEUKEMIA; LUNG CANCER; PANCREAS CANCER; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; THYROID CANCER; CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; NEOPLASM; REVIEW; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 83455238296     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-521     Document Type: Article

References (54)

1. Pharoah PD, Dunning AM, Ponder BA, Easton DF. Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 2004, 4(11):850-860. 10.1038/nrc1476, 15516958.
2. Iscovich J, Howe GR. Cancer incidence patterns (1972-91) among migrants from the Soviet Union to Israel. Cancer Causes Control 1998, 9(1):29-36. 10.1023/A:1008893102428, 9486461.
3. Hecht SS. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 2002, 3(8):461-469. 10.1016/S1470-2045(02)00815-X, 12147432.
4. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001, 411(6835):366-374. 10.1038/35077232, 11357144.
5. Barzilay G, Hickson ID. Structure and function of apurinic/apyrimidinic endonucleases. Bioessays 1995, 17(8):713-719. 10.1002/bies.950170808, 7661852.
6. Tell G, Quadrifoglio F, Tiribelli C, Kelley MR. The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 2009, 11(3):601-620. 10.1089/ars.2008.2194, 2811080, 18976116.
7. Izumi T, Hazra TK, Boldogh I, Tomkinson AE, Park MS, Ikeda S, Mitra S. Requirement for human AP endonuclease 1 for repair of 3'-blocking damage at DNA single-strand breaks induced by reactive oxygen species. Carcinogenesis 2000, 21(7):1329-1334. 10.1093/carcin/21.7.1329, 10874010.
8. Fortini P, Pascucci B, Parlanti E, D'Errico M, Simonelli V, Dogliotti E. The base excision repair: mechanisms and its relevance for cancer susceptibility. Biochimie 2003, 85(11):1053-1071. 10.1016/j.biochi.2003.11.003, 14726013.
9. Bhakat KK, Mantha AK, Mitra S. Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein. Antioxid Redox Signal 2009, 11(3):621-638. 10.1089/ars.2008.2198, 2933571, 18715144.
10. Tell G, Fantini D, Quadrifoglio F. Understanding different functions of mammalian AP endonuclease (APE1) as a promising tool for cancer treatment. Cell Mol Life Sci 2010, 67(21):3589-3608. 10.1007/s00018-010-0486-4, 20706766.
11. Xi T, Jones IM, Mohrenweiser HW. Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics 2004, 83(6):970-979. 10.1016/j.ygeno.2003.12.016, 15177551.
12. Lu J, Zhang S, Chen D, Wang H, Wu W, Wang X, Lei Y, Wang J, Qian J, Fan W, et al. Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility. FASEB J 2009, 23(10):3459-3469. 10.1096/fj.09-136549, 19541747.
13. Lo YL, Jou YS, Hsiao CF, Chang GC, Tsai YH, Su WC, Chen KY, Chen YM, Huang MS, Hu CY, et al. A polymorphism in the APE1 gene promoter is associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2009, 18(1):223-229. 10.1158/1055-9965.EPI-08-0749, 19124501.
14. Wang M, Qin C, Zhu J, Yuan L, Fu G, Zhang Z, Yin C. Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer. DNA Cell Biol 2010, 29(6):303-311. 10.1089/dna.2009.0969, 20218899.
15. Zhou K, Hu D, Lu J, Fan W, Liu H, Chen H, Chen G, Wei Q, Du G, Mao Y, et al. A genetic variant in the APE1/Ref-1 gene promoter -141 T/G may modulate risk of glioblastoma in a Chinese Han population. BMC Cancer 2011, 11:104. 10.1186/1471-2407-11-104, 3072948, 21429202.
16. Berndt SI, Huang WY, Fallin MD, Helzlsouer KJ, Platz EA, Weissfeld JL, Church TR, Welch R, Chanock SJ, Hayes RB. Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma. Cancer Res 2007, 67(3):1395-1404. 10.1158/0008-5472.CAN-06-1390, 17283177.
17. Figueroa JD, Malats N, Real FX, Silverman D, Kogevinas M, Chanock S, Welch R, Dosemeci M, Tardon A, Serra C, et al. Genetic variation in the base excision repair pathway and bladder cancer risk. Hum Genet 2007, 121(2):233-242. 10.1007/s00439-006-0294-y, 17203305.
18. Hadi MZ, Coleman MA, Fidelis K, Mohrenweiser HW, Wilson DM. Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res 2000, 28(20):3871-3879. 10.1093/nar/28.20.3871, 110798, 11024165.
19. Au WW, Salama SA, Sierra-Torres CH. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect 2003, 111(15):1843-1850. 10.1289/ehp.6632, 1241747, 14630517.
20. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22(4):719-748.
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188. 10.1016/0197-2456(86)90046-2, 3802833.
22. Mitra AK, Singh N, Singh A, Garg VK, Agarwal A, Sharma M, Chaturvedi R, Rath SK. Association of polymorphisms in base excision repair genes with the risk of breast cancer: a case-control study in North Indian women. Oncol Res 2008, 17(3):127-135.
23. Misra RR, Ratnasinghe D, Tangrea JA, Virtamo J, Andersen MR, Barrett M, Taylor PR, Albanes D. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett 2003, 191(2):171-178. 10.1016/S0304-3835(02)00638-9, 12618330.
24. Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, Drings P, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 2004, 25(12):2433-2441. 10.1093/carcin/bgh264, 15333465.
25. Hao B, Wang H, Zhou K, Li Y, Chen X, Zhou G, Zhu Y, Miao X, Tan W, Wei Q, et al. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res 2004, 64(12):4378-4384. 10.1158/0008-5472.CAN-04-0372, 15205355.
26. Ito H, Matsuo K, Hamajima N, Mitsudomi T, Sugiura T, Saito T, Yasue T, Lee KM, Kang D, Yoo KY, et al. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis 2004, 25(8):1395-1401. 10.1093/carcin/bgh153, 15044328.
27. Shen M, Berndt SI, Rothman N, Mumford JL, He X, Yeager M, Welch R, Chanock S, Keohavong P, Donahue M, et al. Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China. Anticancer Res 2005, 25(1B):537-542.
28. Moreno V, Gemignani F, Landi S, Gioia-Patricola L, Chabrier A, Blanco I, Gonzalez S, Guino E, Capella G, Canzian F. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res 2006, 12(7 Pt 1):2101-2108.
29. Jiao L, Bondy ML, Hassan MM, Wolff RA, Evans DB, Abbruzzese JL, Li D. Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. Cancer Detect Prev 2006, 30(3):284-291. 10.1016/j.cdp.2006.05.002, 1857309, 16844323.
30. Terry PD, Umbach DM, Taylor JA. APE1 genotype and risk of bladder cancer: evidence for effect modification by smoking. Int J Cancer 2006, 118(12):3170-3173. 10.1002/ijc.21768, 16425270.
31. Wu X, Gu J, Grossman HB, Amos CI, Etzel C, Huang M, Zhang Q, Millikan RE, Lerner S, Dinney CP, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 2006, 78(3):464-479. 10.1086/500848, 1380289, 16465622.
32. Zhang Y, Newcomb PA, Egan KM, Titus-Ernstoff L, Chanock S, Welch R, Brinton LA, Lissowska J, Bardin-Mikolajczak A, Peplonska B, et al. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006, 15(2):353-358. 10.1158/1055-9965.EPI-05-0653, 16492928.
33. Matullo G, Dunning AM, Guarrera S, Baynes C, Polidoro S, Garte S, Autrup H, Malaveille C, Peluso M, Airoldi L, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 2006, 27(5):997-1007.
34. Chen L, Ambrosone CB, Lee J, Sellers TA, Pow-Sang J, Park JY. Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans. J Urol 2006, 175(1):108-112. discussion 112, 10.1016/S0022-5347(05)00042-X, 16406883.
35. Li C, Hu Z, Lu J, Liu Z, Wang LE, El-Naggar AK, Sturgis EM, Spitz MR, Wei Q. Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck. Cancer 2007, 110(4):867-875. 10.1002/cncr.22861, 17614107.
36. Andrew AS, Karagas MR, Nelson HH, Guarrera S, Polidoro S, Gamberini S, Sacerdote C, Moore JH, Kelsey KT, Demidenko E, et al. DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Hum Hered 2008, 65(2):105-118. 10.1159/000108942, 2857629, 17898541.
37. Pardini B, Naccarati A, Novotny J, Smerhovsky Z, Vodickova L, Polakova V, Hanova M, Slyskova J, Tulupova E, Kumar R, et al. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat Res 2008, 638(1-2):146-153. 10.1016/j.mrfmmm.2007.09.008, 17991492.
38. Tse D, Zhai R, Zhou W, Heist RS, Asomaning K, Su L, Lynch TJ, Wain JC, Christiani DC, Liu G. Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk. Cancer Causes Control 2008, 19(10):1077-1083. 10.1007/s10552-008-9171-4, 3106102, 18478337.
39. Huang WY, Gao YT, Rashid A, Sakoda LC, Deng J, Shen MC, Wang BS, Han TQ, Zhang BH, Chen BE, et al. Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China. Carcinogenesis 2008, 29(1):100-105.
40. Chiang FY, Wu CW, Hsiao PJ, Kuo WR, Lee KW, Lin JC, Liao YC, Juo SH. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma. Clin Cancer Res 2008, 14(18):5919-5924. 10.1158/1078-0432.CCR-08-0906, 18779313.
41. Smith TR, Levine EA, Freimanis RI, Akman SA, Allen GO, Hoang KN, Liu-Mares W, Hu JJ. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 2008, 29(11):2132-2138. 10.1093/carcin/bgn193, 2722862, 18701435.
42. Gangwar R, Ahirwar D, Mandhani A, Mittal RD. Influence of XPD and APE1 DNA repair gene polymorphism on bladder cancer susceptibility in north India. Urology 2009, 73(3):675-680. 10.1016/j.urology.2008.09.043, 19041121.
43. Agachan B, Kucukhuseyin O, Aksoy P, Turna A, Yaylim I, Gormus U, Ergen A, Zeybek U, Dalan B, Isbir T. Apurinic/apyrimidinic endonuclease (APE1) gene polymorphisms and lung cancer risk in relation to tobacco smoking. Anticancer Res 2009, 29(6):2417-2420.
44. Deng Q, Sheng L, Su D, Zhang L, Liu P, Lu K, Ma S. Genetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast China. Med Oncol 2011, 28(3):667-672. 10.1007/s12032-010-9507-2, 20354815.
45. Palli D, Polidoro S, D'Errico M, Saieva C, Guarrera S, Calcagnile AS, Sera F, Allione A, Gemma S, Zanna I, et al. Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer. Mutagenesis 2010, 25(6):569-575. 10.1093/mutage/geq042, 20817763.
46. Jelonek K, Gdowicz-Klosok A, Pietrowska M, Borkowska M, Korfanty J, Rzeszowska-Wolny J, Widlak P. Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet 2010, 51(3):343-352. 10.1007/BF03208865, 20720310.
47. Cao Q, Qin C, Meng X, Ju X, Ding Q, Wang M, Zhu J, Wang W, Li P, Chen J, et al. Genetic polymorphisms in APE1 are associated with renal cell carcinoma risk in a chinese population. Mol Carcinog 2011, 50(11):863-870. 10.1002/mc.20791, 21538578.
48. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56(2):455-463. 10.1111/j.0006-341X.2000.00455.x, 10877304.
49. Lindahl T. Recognition and processing of damaged DNA. J Cell Sci Suppl 1995, 19:73-77.
50. Hu JJ, Smith TR, Miller MS, Lohman K, Case LD. Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ Mol Mutagen 2002, 39(2-3):208-215. 10.1002/em.10058, 11921191.
51. Gu D, Wang M, Zhang Z, Chen J. The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies. Mutagenesis 2009, 24(6):507-512. 10.1093/mutage/gep036, 19762350.
52. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, Phillips DH, Canzian F, Haugen A. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006, 27(3):560-567.
53. De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, Claes K, Velghe A, Van Meerbeeck J, Thierens H. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res 2007, 631(2):101-110.
54. Canbay E, Agachan B, Gulluoglu M, Isbir T, Balik E, Yamaner S, Bulut T, Cacina C, Eraltan IY, Yilmaz A, et al. Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer. Anticancer Res 2010, 30(4):1359-1364.